Anthony Polverino

4.1k total citations · 2 hit papers
29 papers, 2.8k citations indexed

About

Anthony Polverino is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Anthony Polverino has authored 29 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Anthony Polverino's work include Protein Kinase Regulation and GTPase Signaling (9 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Anthony Polverino is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (9 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Anthony Polverino collaborates with scholars based in United States, Australia and Netherlands. Anthony Polverino's co-authors include Michael Wigler, Linda Van Aelst, S Marcus, Maureen M. Barr, Scott D. Patterson, Michael A. White, Charles A. Nicolette, Audrey Minden, Michael Karin and Melanie H. Cobb and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Anthony Polverino

29 papers receiving 2.7k citations

Hit Papers

Multiple ras functions can contribute to mammalian cell t... 1993 2026 2004 2015 1995 1993 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony Polverino United States 18 2.3k 697 463 240 161 29 2.8k
Walter Pyerin Germany 31 1.9k 0.8× 554 0.8× 288 0.6× 197 0.8× 104 0.6× 105 2.9k
Julie Milanini France 15 1.3k 0.6× 395 0.6× 317 0.7× 542 2.3× 154 1.0× 19 2.0k
Gilles Ponzio France 28 1.6k 0.7× 447 0.6× 342 0.7× 562 2.3× 198 1.2× 53 2.3k
Jean‐Marc Brondello France 21 2.0k 0.9× 413 0.6× 277 0.6× 548 2.3× 362 2.2× 43 2.9k
Yasuhisa Fukui Japan 35 3.4k 1.5× 801 1.1× 1.1k 2.4× 310 1.3× 459 2.9× 85 4.5k
Roberta Bortul Italy 26 1.7k 0.7× 349 0.5× 220 0.5× 219 0.9× 238 1.5× 60 2.2k
Stefan Kammerer Germany 24 1.5k 0.6× 319 0.5× 155 0.3× 171 0.7× 157 1.0× 38 2.0k
Julio C. Tapia Chile 24 1.1k 0.5× 309 0.4× 296 0.6× 282 1.2× 115 0.7× 60 1.6k
Laura Moro Italy 23 1.1k 0.5× 436 0.6× 408 0.9× 225 0.9× 190 1.2× 55 2.2k
Janet H. Scott United States 24 762 0.3× 687 1.0× 238 0.5× 424 1.8× 197 1.2× 49 1.9k

Countries citing papers authored by Anthony Polverino

Since Specialization
Citations

This map shows the geographic impact of Anthony Polverino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Polverino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Polverino more than expected).

Fields of papers citing papers by Anthony Polverino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Polverino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Polverino. The network helps show where Anthony Polverino may publish in the future.

Co-authorship network of co-authors of Anthony Polverino

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Polverino. A scholar is included among the top collaborators of Anthony Polverino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Polverino. Anthony Polverino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coxon, Angela, James Bready, Stephen A. Kaufman, et al.. (2012). Anti-tumor activity of motesanib in a medullary thyroid cancer model.. PubMed. 35(2). 181–90. 22 indexed citations
2.
Coxon, Angela, Stephen A. Kaufman, Man Xu, et al.. (2012). Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non–small-cell lung cancer xenograft models. Molecular Cancer. 11(1). 70–70. 19 indexed citations
3.
Kruser, Tim J., Deric L. Wheeler, Eric A. Armstrong, et al.. (2010). Augmentation of Radiation Response by Motesanib, a Multikinase Inhibitor that Targets Vascular Endothelial Growth Factor Receptors. Clinical Cancer Research. 16(14). 3639–3647. 13 indexed citations
4.
Caenepeel, Sean, Lisa Renshaw-Gegg, Tammy L. Bush, et al.. (2010). Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors. Journal of Experimental & Clinical Cancer Research. 29(1). 96–96. 15 indexed citations
5.
Kaufman, Stephen A., Man Xu, Hongyu Wang, et al.. (2010). Abstract 1380: Antitumor activity of motesanib alone and in combination with chemotherapy in xenograft models of human non-small cell lung cancer. Cancer Research. 70(8_Supplement). 1380–1380. 1 indexed citations
6.
Choquette, Deborah M., Yohannes Teffera, Anthony Polverino, & Jean-Christophe Harmange. (2008). Discovery of novel 1,2,3,4-tetrahydroisoquinolines and 3,4-dihydroisoquinoline-1(2H)-ones as potent and selective inhibitors of KDR: Synthesis, SAR, and pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 18(14). 4054–4058. 16 indexed citations
7.
Bauer, David, Douglas A. Whittington, Angela Coxon, et al.. (2008). Evaluation of indazole-based compounds as a new class of potent KDR/VEGFR-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(17). 4844–4848. 18 indexed citations
8.
Rosen, Lee S., Razelle Kurzrock, Marilyn Mulay, et al.. (2007). Safety, Pharmacokinetics, and Efficacy of AMG 706, an Oral Multikinase Inhibitor, in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 25(17). 2369–2376. 152 indexed citations
9.
Marcus, Stevan, et al.. (2007). RAS Function and Protein Kinase Cascades. Novartis Foundation symposium. 176. 53–66. 1 indexed citations
10.
Lacey, David L., Hong Tan, John Lu, et al.. (2000). Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in Vivo. American Journal Of Pathology. 157(2). 435–448. 321 indexed citations
11.
Watts, Julian D., M. F. Gu, Scott D. Patterson, Ruedi Aebersold, & Anthony Polverino. (1999). On the complexities of ceramide changes in cells undergoing apoptosis: lack of evidence for a second messenger function in apoptotic induction. Cell Death and Differentiation. 6(2). 105–114. 35 indexed citations
12.
Polverino, Anthony & Scott D. Patterson. (1997). Selective Activation of Caspases During Apoptotic Induction in HL-60 Cells. Journal of Biological Chemistry. 272(11). 7013–7021. 133 indexed citations
13.
Watts, Julian D., M. F. Gu, Anthony Polverino, Scott D. Patterson, & Ruedi Aebersold. (1997). Fas-induced apoptosis of T cells occurs independently of ceramide generation. Proceedings of the National Academy of Sciences. 94(14). 7292–7296. 117 indexed citations
14.
Polverino, Anthony, Jeffrey A. Frost, Peirong Yang, et al.. (1995). Activation of Mitogen-activated Protein Kinase Cascades by p21-activated Protein Kinases in Cell-free Extracts of Xenopus Oocytes. Journal of Biological Chemistry. 270(44). 26067–26070. 91 indexed citations
15.
White, Michael A., Charles A. Nicolette, Audrey Minden, et al.. (1995). Multiple ras functions can contribute to mammalian cell transformation. Cell. 80(4). 533–541. 596 indexed citations breakdown →
16.
Marcus, S, Anthony Polverino, Maureen M. Barr, & Michael Wigler. (1994). Complexes between STE5 and components of the pheromone-responsive mitogen-activated protein kinase module.. Proceedings of the National Academy of Sciences. 91(16). 7762–7766. 204 indexed citations
17.
Aelst, Linda Van, Maureen M. Barr, S Marcus, Anthony Polverino, & Michael Wigler. (1993). Complex formation between RAS and RAF and other protein kinases.. Proceedings of the National Academy of Sciences. 90(13). 6213–6217. 552 indexed citations breakdown →
18.
Polverino, Anthony, Bernard P. Hughes, & Greg J. Barritt. (1991). Inhibition of Ca2+ inflow causes an abrupt cessation of growth-factor-induced repetitive free Ca2+ transients in single NIH-3T3 cells. Biochemical Journal. 278(3). 849–855. 13 indexed citations
19.
Polverino, Anthony & Greg J. Barritt. (1988). On the source of the vasopressin-induced increases in diacylglycerol in hepatocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 970(1). 75–82. 16 indexed citations
20.
Bochner, Felix, Gerard J. Graham, Anthony Polverino, et al.. (1987). Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis. European Journal of Clinical Pharmacology. 32(2). 153–158. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026